CN102093377A - Chiral compound and liquid crystal composition containing the same - Google Patents
Chiral compound and liquid crystal composition containing the same Download PDFInfo
- Publication number
- CN102093377A CN102093377A CN2009102534318A CN200910253431A CN102093377A CN 102093377 A CN102093377 A CN 102093377A CN 2009102534318 A CN2009102534318 A CN 2009102534318A CN 200910253431 A CN200910253431 A CN 200910253431A CN 102093377 A CN102093377 A CN 102093377A
- Authority
- CN
- China
- Prior art keywords
- liquid crystal
- chiral compound
- crystal composition
- formula
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 49
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 239000001257 hydrogen Substances 0.000 claims abstract description 9
- 125000003118 aryl group Chemical group 0.000 claims abstract description 8
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 6
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 5
- 150000002367 halogens Chemical class 0.000 claims abstract description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- 150000002825 nitriles Chemical class 0.000 claims abstract description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 4
- 150000002431 hydrogen Chemical class 0.000 claims abstract 6
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 claims description 29
- 239000004988 Nematic liquid crystal Substances 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 238000009472 formulation Methods 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 8
- 230000003287 optical effect Effects 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 description 9
- 229960002479 isosorbide Drugs 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 125000000524 functional group Chemical group 0.000 description 7
- KLDXJTOLSGUMSJ-BXKVDMCESA-N (3s,3as,6s,6as)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol Chemical compound O[C@H]1CO[C@H]2[C@@H](O)CO[C@H]21 KLDXJTOLSGUMSJ-BXKVDMCESA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 229910006124 SOCl2 Inorganic materials 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- KLDXJTOLSGUMSJ-UHFFFAOYSA-N 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol Chemical compound OC1COC2C(O)COC21 KLDXJTOLSGUMSJ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 2
- VDWCSCVZVXBLHB-UHFFFAOYSA-N COC1=CC=C(C=CC(=O)O)C=C1.COC1=CC=C(C=CC(=O)O)C=C1 Chemical compound COC1=CC=C(C=CC(=O)O)C=C1.COC1=CC=C(C=CC(=O)O)C=C1 VDWCSCVZVXBLHB-UHFFFAOYSA-N 0.000 description 2
- CGOJOQBYEAVATL-QPJJXVBHSA-N COc1ccc(/C=C/C(Cl)=O)cc1 Chemical compound COc1ccc(/C=C/C(Cl)=O)cc1 CGOJOQBYEAVATL-QPJJXVBHSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000005561 phenanthryl group Chemical group 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 125000002755 pyrazolinyl group Chemical group 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- AKODTHURSNIVNS-UHFFFAOYSA-N (3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl) 3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1C=CC(=O)OC1C2OCC(O)C2OC1 AKODTHURSNIVNS-UHFFFAOYSA-N 0.000 description 1
- ADRUTLJVBQXMTI-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1.C1COCO1 ADRUTLJVBQXMTI-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- SEOXMNRLQRWJGE-OVTYFYGESA-N COc1ccc(/C=C/C(O[C@H](COC23)C2OCC3OC(/C=C/c(cc2)ccc2OC)=O)=O)cc1 Chemical compound COc1ccc(/C=C/C(O[C@H](COC23)C2OCC3OC(/C=C/c(cc2)ccc2OC)=O)=O)cc1 SEOXMNRLQRWJGE-OVTYFYGESA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004985 Discotic Liquid Crystal Substance Substances 0.000 description 1
- KLDXJTOLSGUMSJ-GQNXIQCSSA-N O[C@H](COC12)C1OC[C@H]2O Chemical compound O[C@H](COC12)C1OC[C@H]2O KLDXJTOLSGUMSJ-GQNXIQCSSA-N 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- -1 anthracyl (anthracyl) Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000004298 light response Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000007699 photoisomerization reaction Methods 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940124543 ultraviolet light absorber Drugs 0.000 description 1
Images
Landscapes
- Liquid Crystal Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
技术领域technical field
本发明是涉及一种手性化合物(chiral compound),且特别是涉及一种具有高螺旋扭转力的光应答型手性化合物与含有此化合物的液晶组合物。The present invention relates to a chiral compound, and in particular to a light-responsive chiral compound with high helical twisting force and a liquid crystal composition containing the compound.
背景技术Background technique
胆甾型液晶显示器具有不需背光源及偏光片即可反射外界光源的特色,因而较一般显示器模式更具有能够节省能量,自发的反射光线特性可针对不同波长光线反射,因此不需彩色滤光片可达到彩色显示器的需求。Cholesteric liquid crystal display has the characteristics of reflecting external light source without backlight and polarizer, so it can save energy compared with general display mode, and the spontaneous reflection light characteristic can reflect light of different wavelengths, so no color filter is required Chips can meet the needs of color displays.
胆甾型液晶材料(Cholesteric liquid crystal)又可称为手性向列型(chiralnematic)液晶材料,由单纯的向列型液晶与特殊的手性添加剂(chiral dopant)所组成,原本呈现向列型排列的液晶材料受手性添加剂的影响,产生较TN(twisted nematic,扭转向列型)或STN(super twisted nematic,超扭转向列型液晶)更强烈的扭转。Cholesteric liquid crystal material (Cholesteric liquid crystal) can also be called chiral nematic liquid crystal material, which is composed of pure nematic liquid crystal and special chiral dopant, originally showing a nematic arrangement The liquid crystal material is affected by chiral additives, which produces a stronger twist than TN (twisted nematic, twisted nematic) or STN (super twisted nematic, super twisted nematic liquid crystal).
胆甾型液晶材料的螺距p由手性添加剂的浓度(concentration,C)与其螺旋扭转力(helical twisting power,HTP)决定,有以下关系式:The helical pitch p of the cholesteric liquid crystal material is determined by the concentration (concentration, C) of the chiral additive and its helical twisting power (HTP), which has the following relationship:
p=1/(HTP·C)。p=1/(HTP·C).
由于胆甾型液晶反射的波长由螺距决定,而配方的螺距又受到配方中所使用的手性添加剂的螺旋扭转力与浓度控制。因此,在特定的螺距要求下,螺旋扭转力(HTP)越高,所需添加的手性分子浓度就越低。若液晶母体(多层向列型液晶)对于此旋光液晶分子的溶解度不佳,将使得液晶组合物的调控受到限制。Since the wavelength reflected by the cholesteric liquid crystal is determined by the helical pitch, the helical pitch of the formulation is controlled by the helical torsion force and concentration of the chiral additive used in the formulation. Therefore, under a specific pitch requirement, the higher the helix twisting force (HTP), the lower the concentration of chiral molecules that need to be added. If the liquid crystal matrix (multilayer nematic liquid crystal) has poor solubility for the optically active liquid crystal molecules, the control of the liquid crystal composition will be limited.
制作光写入型胆甾型液晶显示器需要使用具有高螺旋扭转力的光应答型手性化合物,使其在液晶中可因照光产生分子的构形改变,进而产生螺旋扭转力(HTP)改变,使胆甾型液晶的螺距(p)改变,达到改变不同反射光颜色。然而,若手性化合物本身具有颜色(例如桔红色的偶氮分子)则添加至向列型液晶母体中会干扰反射光的颜色,也不适用于光写入型的胆甾型液晶配方。The production of optically-written cholesteric liquid crystal displays requires the use of light-responsive chiral compounds with high helical torsion force, so that they can change the configuration of molecules in the liquid crystal due to light irradiation, and then produce helical torsion force (HTP) changes. Change the pitch (p) of the cholesteric liquid crystal to change the color of different reflected light. However, if the chiral compound itself has a color (such as an orange-red azo molecule), adding it to the nematic liquid crystal matrix will interfere with the color of reflected light, and it is not suitable for optically writing cholesteric liquid crystal formulations.
因此,光应答型手性化合物需具备高螺旋扭转力、与液晶配方有良好的溶解度、无色等特性方可添加至液晶配方中,才能达到可光写入颜色的功效。另一方面,所得的液晶组合物应具有高色纯度与稳定的温度依存性(temperaturedependence)等特性。Therefore, light-responsive chiral compounds must have high helical twisting force, good solubility with liquid crystal formulations, and colorless properties before they can be added to liquid crystal formulations to achieve the effect of optically writing colors. On the other hand, the obtained liquid crystal composition should have characteristics such as high color purity and stable temperature dependence.
发明内容Contents of the invention
本发明的目的在于提供一种适用于光写入型的胆甾型液晶配方的手性化合物。The object of the present invention is to provide a chiral compound suitable for optical writing type cholesteric liquid crystal formulation.
本发明提供一种手性化合物,具有如式(I)或式(II)的结构:The present invention provides a chiral compound having a structure such as formula (I) or formula (II):
其中R1、R2各自独立,是择自氢、羟基、卤素、胺基、硝基、腈基、C1-10烷基、C1-10烷氧基、芳香基、杂芳香基、环烷基、或杂环基。Wherein R 1 and R 2 are independently selected from hydrogen, hydroxyl, halogen, amino, nitro, nitrile, C 1-10 alkyl, C 1-10 alkoxy, aryl, heteroaryl, ring Alkyl, or heterocyclic.
本发明还提供一种液晶组合物,包括:100重量份的液晶主体;以及,3-20重量份如前述的手性化合物。The present invention also provides a liquid crystal composition, comprising: 100 parts by weight of a liquid crystal host; and 3-20 parts by weight of the aforementioned chiral compound.
本发明的优点在于:本发明的手性化合物具有单一的光应答官能基,因而由其所配制出的胆甾型液晶配方的波峰半高宽(Δλ)较小,因此呈现较佳的色纯度;具备高螺旋扭转力(HTP>30μm-1),添加少量于向列型液晶中即可产生胆甾型液晶相;与液晶配方溶解度佳且本身无色;所得的胆甾型液晶配方的反射波长的温度依存性低(dλ/dT的绝对值小于1),具有较稳定的显示品质。The advantage of the present invention is that: the chiral compound of the present invention has a single light-responsive functional group, so the half-maximum width (Δλ) of the cholesteric liquid crystal formula prepared by it is relatively small, so it presents better color purity ;With high helical torsion force (HTP>30μm -1 ), adding a small amount to nematic liquid crystal can produce cholesteric liquid crystal phase; good solubility with liquid crystal formula and colorless; the reflection of the obtained cholesteric liquid crystal formula The temperature dependence of the wavelength is low (the absolute value of dλ/dT is less than 1), and it has relatively stable display quality.
为让本发明的上述和其它目的、特征和优点能更明显易懂,下文特举出较佳实施例,并配合所附附图,作详细说明如下:In order to make the above-mentioned and other objects, features and advantages of the present invention more comprehensible, the preferred embodiments are specifically listed below, together with the accompanying drawings, and are described in detail as follows:
附图说明Description of drawings
图1显示实施例1与比较例1所制得的液晶配方在不同波长的波峰半高宽;Fig. 1 shows the liquid crystal formula that embodiment 1 and comparative example 1 make are at the peak full width at half maximum of different wavelengths;
图2显示比较例2所制得的液晶配方的反射波长与温度的关系图;Fig. 2 shows the relationship figure of the reflection wavelength and temperature of the liquid crystal formula that comparative example 2 makes;
图3显示实施例1所制得的液晶配方的反射波长与温度的关系图。FIG. 3 shows the relationship between reflection wavelength and temperature of the liquid crystal formulation prepared in Example 1.
具体实施方式Detailed ways
制作光写入型胆甾型液晶显示器需要使用具有高螺旋扭转力的光应答型手性化合物,此光应答型手性化合物不能有颜色,要不然会干扰反射光的波长。为了达到上述需求,本发明是以不对称1,4:3,6-双脱水甘露醇(isomannide)及异山梨醇(isosorbide)手性分子做衍生(如下所示),此结构具有很好的HTP(HelicalTwisting Power)添加少量于向列型液晶中即可产生胆甾型液晶相,结构中再搭配压克力官能基以达到光应答的功效。The production of optically writeable cholesteric liquid crystal displays requires the use of light-responsive chiral compounds with high helical twisting force. This light-responsive chiral compound cannot have color, or it will interfere with the wavelength of reflected light. In order to meet the above requirements, the present invention uses asymmetric 1,4:3,6-dianhydromannitol (isomannide) and isosorbide (isosorbide) chiral molecules to do derivation (as shown below), this structure has a good Adding a small amount of HTP (Helical Twisting Power) to the nematic liquid crystal can produce a cholesteric liquid crystal phase, and acrylic functional groups are added to the structure to achieve the effect of photoresponse.
本发明的手性化合物,具有如式(I)或式(II)的结构:The chiral compound of the present invention has a structure such as formula (I) or formula (II):
其中R1、R2各自独立,是择自氢、羟基、卤素、胺基、硝基、腈基、C1-10烷基、C1-10烷氧基、芳香基、杂芳香基、环烷基、或杂环基。其中C1-10烷基、C1-10烷氧基可为直链或具有支链者。在一实施例中,R1、R2各自独立,是择自氢、C1-10烷基、或C1-10烷氧基。在另一实施例中,R1、R2皆为烷氧基。Wherein R 1 and R 2 are independently selected from hydrogen, hydroxyl, halogen, amino, nitro, nitrile, C 1-10 alkyl, C 1-10 alkoxy, aryl, heteroaryl, ring Alkyl, or heterocyclic. Among them, C 1-10 alkyl and C 1-10 alkoxy may be linear or branched. In one embodiment, R 1 and R 2 are independently selected from hydrogen, C 1-10 alkyl, or C 1-10 alkoxy. In another embodiment, both R 1 and R 2 are alkoxy.
在上述中,“芳香基(aryl)”代表一单环或多环系统的碳氢芳香环,例如:苯基,甲苯基,萘基,四氢化萘基(tetrahydronaphthyl),联苯基(biphenyl),菲基(phenanthryl)、蒽基(anthracyl)等。In the above, "aryl (aryl)" represents a monocyclic or polycyclic hydrocarbon aromatic ring, such as: phenyl, tolyl, naphthyl, tetrahydronaphthyl, biphenyl , Phenanthryl (phenanthryl), anthracyl (anthracyl) and so on.
“杂芳香基(heteroaryl)”代表结构中含有一或多个杂原子(如氮、氧、硫)取代的芳香基,例如吡啶基(pyridyl),呋喃基(furyl),噻吩基(thienyl),咪唑基(imidazolyl)等。"Heteroaryl" represents an aromatic group substituted by one or more heteroatoms (such as nitrogen, oxygen, sulfur) in the structure, such as pyridyl (pyridyl), furyl (furyl), thienyl (thienyl), imidazolyl, etc.
“环烷基(cycloalkyl)”代表一非芳香族的碳氢单环或多环,可含有3~12个碳原子,例如环丙基、环丁基、环戊基、环己基、环辛基、二环[2.2.1]辛基等。"Cycloalkyl" represents a non-aromatic hydrocarbon monocyclic or polycyclic ring, which may contain 3 to 12 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclooctyl , Bicyclo[2.2.1]octyl, etc.
“杂环基(heterocyclic)”代表结构中含有一或多个杂原子(如氮、氧、硫)取代的环烷基,例如1,3-二氧戊环(1,3-dioxolane)、吡咯烷基(pyrrolidinyl)、吡唑啉基(pyrazolinyl)、哌啶基(piperidinyl)、哌嗪基(piperazinyl)、四氢呋喃基(tetrahydrofuryl)等。"Heterocyclic" represents a cycloalkyl group substituted by one or more heteroatoms (such as nitrogen, oxygen, sulfur) in the structure, such as 1,3-dioxolane (1,3-dioxolane), pyrrole Alkyl (pyrrolidinyl), pyrazolinyl (pyrazolinyl), piperidinyl (piperidinyl), piperazinyl (piperazinyl), tetrahydrofuryl (tetrahydrofuryl), etc.
此外,上述的芳香基、杂芳香基、环烷基、或杂环基上的一或多个氢原子可进一步被卤素、羟基、胺基或其它官能基取代。In addition, one or more hydrogen atoms on the above-mentioned aryl, heteroaryl, cycloalkyl, or heterocyclic groups may be further substituted by halogen, hydroxyl, amine, or other functional groups.
由式(I)、(II)可知,本发明的手性化合物为不对称的1,4:3,6-双脱水甘露醇及异山梨醇(isomannide/isosorbide)手性化合物,且具有一个光应答(photosensitive)官能基。相较于已知具有两个光应答官能基的化合物(如US6589445所公开的),此单一光应答基的手性化合物可提升胆甾型液晶的色纯度。From the formulas (I) and (II), it can be seen that the chiral compound of the present invention is an asymmetric 1,4:3,6-dianhydromannitol and isosorbide (isomannide/isosorbide) chiral compound, and has a light Response (photosensitive) functional groups. Compared with known compounds having two photoresponsive functional groups (as disclosed in US6589445), the chiral compound with a single photoresponsive group can improve the color purity of cholesteric liquid crystals.
式(I)的手性化合物可从1,4:3,6-双脱水甘露醇(isomannide)经由两步骤酯化反应而成,其反应式如下(R1、R2的定义同前,X代表-OH或-Cl):The chiral compound of formula (I) can be obtained from 1,4:3,6-dianhydromannitol (isomannide) through a two-step esterification reaction, and its reaction formula is as follows (R 1 , R 2 are as defined above, X stands for -OH or -Cl):
同样地,式(II)的手性化合物可从异山梨醇(isosorbide)经由两步骤酯化反应而成,其反应式如下(R1、R2的定义同前,X代表-OH或-Cl):Similarly, the chiral compound of formula (II) can be obtained from isosorbide (isosorbide) through a two-step esterification reaction, and its reaction formula is as follows (R 1 and R 2 are as defined above, X represents -OH or -Cl ):
第一酯化反应通常可在0℃至室温下进行约4小时,第二酯化反应通常可在约80℃下进行约20小时。关于酯化的详细步骤可参见以下实施例的描述。The first esterification reaction can generally be performed at 0° C. to room temperature for about 4 hours, and the second esterification reaction can generally be performed at about 80° C. for about 20 hours. For the detailed steps of esterification, please refer to the description of the following examples.
所制得的手性化合物为白色固体,在向列型液晶配方中有良好的溶解度,且溶解后为无色,因此不会干扰反射光的颜色。此外,本发明的手性化合物通常具有大于30μm-1的高螺旋扭转力(HTP),在较佳实施例中,螺旋扭转力(HTP)可达60μm-1。因此,应用在液晶组合物中只需要添加少量的手性化合物,可避免添加量过高对液晶组合物的液晶相行为与光电特性产生不良的影响。The prepared chiral compound is a white solid, has good solubility in the nematic liquid crystal formula, and is colorless after dissolving, so it will not interfere with the color of reflected light. In addition, the chiral compound of the present invention generally has a high helical torsional force (HTP) greater than 30 μm -1 , and in a preferred embodiment, the helical torsional force (HTP) can reach 60 μm -1 . Therefore, only a small amount of chiral compound needs to be added to the liquid crystal composition, which can avoid adverse effects on the liquid crystal phase behavior and photoelectric properties of the liquid crystal composition due to excessive addition.
本发明的液晶组合物包括:Liquid crystal composition of the present invention comprises:
(a)100重量份的液晶主体;以及(a) 100 parts by weight of a liquid crystal host; and
(b)3-20重量份的式(I)或式(II)手性化合物;较佳约5-15重量份。(b) 3-20 parts by weight of the chiral compound of formula (I) or formula (II); preferably about 5-15 parts by weight.
本发明的手性化合物可作为光应答型的手性添加剂,添加至向列型(Nematic)液晶、近晶型(Smectic)液晶、或盘状(discotic)液晶。较佳者,可添加在向列型液晶中形成胆甾型液晶配方,作为光写入型胆甾型液晶显示器的应用。The chiral compound of the present invention can be used as a photoresponsive chiral additive and added to nematic liquid crystals, smectic liquid crystals, or discotic liquid crystals. Preferably, it can be added to form a cholesteric liquid crystal formula in a nematic liquid crystal, as an application of an optical writing type cholesteric liquid crystal display.
所使用的液晶主体可含有或不含有可聚合官能基(polymerizable group)。此外,本发明的液晶组合物也可视需要加入可聚合单体、聚合引发剂、粘结树脂(binder resin)、溶剂、表面活性剂、增粘剂、紫外光吸收剂、或其它的手性添加剂。有关于液晶主体与其它成份的具体实例可参考US 6589445。The liquid crystal host used may or may not contain polymerizable groups. In addition, the liquid crystal composition of the present invention may also add polymerizable monomers, polymerization initiators, binder resins, solvents, surfactants, tackifiers, ultraviolet light absorbers, or other chiral additive. For specific examples of liquid crystal hosts and other components, please refer to US 6589445.
本发明的光应答型手性化合物可因照光产生分子的构形改变,进而产生螺旋扭转力(HTP)改变,使胆甾型液晶的螺距(p)改变,达到改变不同反射光颜色。依据照光时间长短,可使本发明的液晶组合物产生50~250nm不等的波长偏移,以在可见光(380nm-800nm)的范围呈现包含红色(R)、绿色(G)、蓝色(B)等特定反射波长。照光所使用的光源以紫外光较佳,因其具有较高的能量,可缩短分子构形改变所需的时间。The light-responsive chiral compound of the present invention can change the configuration of the molecule due to light irradiation, and then produce a change in the helical torsion force (HTP), so that the pitch (p) of the cholesteric liquid crystal can be changed to achieve different colors of reflected light. According to the length of illumination time, the liquid crystal composition of the present invention can produce a wavelength shift ranging from 50 to 250 nm, so as to display red (R), green (G), blue (B) in the range of visible light (380 nm-800 nm). ) and other specific reflection wavelengths. The light source used for illumination is preferably ultraviolet light, because it has higher energy and can shorten the time required for molecular configuration change.
相较于已知具有两个光应答官能基的化合物,利用本发明单一光应答官能基的手性化合物所配制出的胆甾型液晶配方的波峰半高宽(Δλ)较小,因此呈现较佳的色纯度。此外,所得的胆甾型液晶配方的反射波长的温度依存性低(dλ/dT的绝对值小于1),具有较稳定的显示品质。Compared with known compounds having two photoresponsive functional groups, the cholesteric liquid crystal formulation prepared by the chiral compound with a single photoresponsive functional group of the present invention has a smaller peak half-width (Δλ), and therefore presents a relatively Excellent color purity. In addition, the obtained cholesteric liquid crystal formulation has low temperature dependence of reflection wavelength (the absolute value of dλ/dT is less than 1), and has relatively stable display quality.
本发明的液晶组合物也可与高分子单体形成混合溶液,利用热或照光的方式使高分子单体聚合,随聚合过程中单体与液晶间溶解度降低而产生相分离,使液晶以微滴形态均匀分散在高分子中,成为高分子分散型胆甾型液晶(polymer dispersed cholesteric liquid crystal,PDChLC)。The liquid crystal composition of the present invention can also form a mixed solution with high molecular monomers, and polymerize the high molecular monomers by means of heat or light, and phase separation occurs as the solubility between the monomers and liquid crystals decreases during the polymerization process, so that the liquid crystals are slightly The droplet form is evenly dispersed in the polymer to become a polymer dispersed cholesteric liquid crystal (PDChLC).
综上所述,本发明的手性化合物至少提供以下优点:In summary, the chiral compound of the present invention at least provides the following advantages:
1.具备高螺旋扭转力(HTP>30μm-1)。1. Possess high helical torsion force (HTP>30μm -1 ).
2.与液晶配方溶解度佳且本身无色。2. Good solubility with liquid crystal formula and colorless itself.
3.所配制的胆甾型液晶配方具有高色纯度。3. The prepared cholesteric liquid crystal formula has high color purity.
4.具有稳定的温度依存性(dλ/dT的绝对值小于1)。4. It has stable temperature dependence (the absolute value of dλ/dT is less than 1).
通过本发明的手性化合物,可制得一高色纯度、显示品质稳定的光写入型胆甾型液晶显示器以作各种广泛应用,例如电子卷标、电子书、智能卡、平面显示器、大型广告看板,以及手写计算机等。Through the chiral compound of the present invention, an optical writing cholesteric liquid crystal display with high color purity and stable display quality can be obtained for various wide applications, such as electronic labels, e-books, smart cards, flat-panel displays, large-scale Advertising billboards, and handwriting computers, etc.
本发明的液晶组合物也可用于制作其它类型的显示装置,例如扭转向列型(TN)显示器、超扭转向列型(STN)显示器、彩色超扭转向列型(CSTN)显示器及薄膜晶体管型(TFT)显示器。除此之外,本发明的液晶组合物尚可用于制作反射式偏光板、胆甾型型反射式偏光板、反射板、光学补偿膜、延迟膜、彩色滤光、光致变色涂料或液晶染料等。The liquid crystal composition of the present invention can also be used for making other types of display devices, such as twisted nematic (TN) displays, super twisted nematic (STN) displays, color super twisted nematic (CSTN) displays and thin film transistor type displays. (TFT) display. In addition, the liquid crystal composition of the present invention can also be used to make reflective polarizers, cholesteric reflective polarizers, reflectors, optical compensation films, retardation films, color filters, photochromic coatings or liquid crystal dyes wait.
【比较例1:双光应答基的手性化合物1】[Comparative Example 1: Chiral Compound 1 with Double Photoresponse Group]
称取4-甲氧基肉桂酸(4-Methoxycinnamic acid)(10.7g,60mmol)放入双颈瓶中,并架好回流管,利用加料管将SOCl2滴入,在50℃下反应约3小时后,用真空泵将多余的SOCl2抽掉,剩下淡黄色液体。另一方面,将isomannide(7.3g,50mmol)溶于吡啶(pyridine)(20ml)及二氯甲烷(50ml)中,缓慢用加料管滴入上液,室温反应约20小时,反应结束以HCl(aq)和CH2Cl2萃取,取有机层抽干后得淡黄色油状物,以MeOH再结晶,可得到白色固体,产率为28.7%(6.7g,14.4mmol)。产物的HTP=45μm-1。Weigh 4-methoxycinnamic acid (4-Methoxycinnamic acid) (10.7g, 60mmol) into a double-necked bottle, and set up a reflux tube, use the feeding tube to drop SOCl2 , and react at 50 ° C for about 3 After 2 hours, the excess SOCl2 was sucked off with a vacuum pump, leaving a pale yellow liquid. On the other hand, isomannide (7.3g, 50mmol) was dissolved in pyridine (20ml) and dichloromethane (50ml), slowly dripped into the upper solution with a feeding tube, and reacted at room temperature for about 20 hours. After the reaction was completed, HCl ( aq) and CH 2 Cl 2 extraction, the organic layer was taken and dried to obtain a pale yellow oil, which was recrystallized from MeOH to obtain a white solid with a yield of 28.7% (6.7 g, 14.4 mmol). HTP of the product = 45 μm -1 .
【比较例2:双光应答基的手性化合物2】[Comparative Example 2: Chiral Compound 2 with Double Photoresponse Group]
合成步骤同比较例1,但将isomannide改为isosorbide,所得产物为白色固体,HTP=45μm-1。The synthesis procedure was the same as that of Comparative Example 1, but the isomannide was changed to isosorbide, and the obtained product was a white solid with HTP=45 μm -1 .
【实施例1】【Example 1】
称取4-甲氧基肉桂酸(4-Methoxycinnamic acid)(10.7g,60mmol)放入双颈瓶中,并架好回流管,利用加料管将SOCl2滴入,在50℃下反应约3小时后,用真空泵将多余的SOCl2抽掉,剩下淡黄色液体。另一方面,将isosorbide(7.3g,50mmol)溶于吡啶(20ml)及二氯甲烷(50ml)中,缓慢用加料管滴入上液,冰浴下反应约4小时,反应结束以HCl(aq)和CH2Cl2萃取,取有机层抽干后得淡黄色油状物,先用MeOH再结晶,得到不要的副产物后,再用管柱层析分离可得产物,产率为33.3%(5.1g,16.7mmol)。Weigh 4-methoxycinnamic acid (4-Methoxycinnamic acid) (10.7g, 60mmol) into a double-necked bottle, and set up a reflux tube, use the feeding tube to drop SOCl2 , and react at 50 ° C for about 3 After 2 hours, the excess SOCl2 was sucked off with a vacuum pump, leaving a pale yellow liquid. On the other hand, isosorbide (7.3g, 50mmol) was dissolved in pyridine (20ml) and dichloromethane (50ml), slowly dripped into the upper solution with a feeding tube, and reacted for about 4 hours under ice-cooling . ) and CH 2 Cl 2 extraction, the organic layer was taken and dried to obtain a light yellow oil, which was first recrystallized with MeOH to obtain unwanted by-products, and then separated by column chromatography to obtain the product with a yield of 33.3% ( 5.1 g, 16.7 mmol).
称取3-(4-甲氧基-苯基)-丙烯酸6-羟基-六氢-氟[3,2-b]呋喃-3-基酯(3-(4-Methoxy-phenyl)-acrylic acid 6-hydroxy-hexahydro-furo[3,2-b]furan-3-ylester)(3.8g,15mmol)放入双颈瓶中,并架好回流管,利用加料管将SOCl2滴入,在50℃下反应约3小时后,用真空泵将多余的SOCl2抽掉,剩下白色固体。另一方面,将前一步所得白色固体(1.5g,5mmol)溶于吡啶(50ml)中,缓慢用加料管滴入上液,再加入少量4-二甲胺基吡啶(4-Dimethylaminopyridine),加热到80℃反应约20小时,反应结束以HCl(aq)和乙酸乙酯萃取,取有机层抽干后得淡黄色油状物,利用管柱层析分离可得产物为白色固体,产率为21%(0.6g,1mmol)。产物的HTP=60μm-1。Weigh 3-(4-methoxy-phenyl)-acrylic acid 6-hydroxy-hexahydro-fluoro[3,2-b]furan-3-yl ester (3-(4-Methoxy-phenyl)-acrylic acid 6-hydroxy-hexahydro-furo[3,2-b]furan-3-ylester) (3.8g, 15mmol) was put into the double-necked bottle, and the reflux tube was set up, and SOCl was dripped in by using the feeding tube, at 50 After reacting at °C for about 3 hours, the excess SOCl2 was sucked off with a vacuum pump, leaving a white solid. On the other hand, the white solid (1.5g, 5mmol) obtained in the previous step was dissolved in pyridine (50ml), slowly dripped into the upper liquid with a feeding tube, then added a small amount of 4-dimethylaminopyridine (4-Dimethylaminopyridine), and heated Reaction at 80°C for about 20 hours, after the reaction was completed, extracted with HCl (aq) and ethyl acetate, the organic layer was taken and dried to obtain a light yellow oil, which was separated by column chromatography to obtain a white solid with a yield of 21 % (0.6 g, 1 mmol). HTP of the product = 60 μm -1 .
【实施例2】[Example 2]
合成步骤同实施例1,但将isosorbide改为isomannide,所得产物为白色固体,HTP=33μm-1。The synthesis procedure is the same as in Example 1, but isosorbide is changed to isomannide, and the obtained product is a white solid, HTP=33 μm -1 .
【照光评估结果】【Lighting evaluation results】
将0.15克实施例1的手性化合物配置于2.94克向列型液晶主体BL-087(Merck)中(双折射率为0.24)中,以UV灯(365nm;~2mW/cm2)照光前的胆甾型液晶波长为568nm,照光270秒后为782nm,波长偏移高达214nm。0.15 g of the chiral compound of Example 1 was configured in 2.94 g of nematic liquid crystal host BL-087 (Merck) (birefringence index 0.24), and before irradiation with a UV lamp (365nm; ~2mW/cm 2 ). The wavelength of cholesteric liquid crystal is 568nm, and it is 782nm after being illuminated for 270 seconds, and the wavelength shift is as high as 214nm.
【色纯度分析】【Color Purity Analysis】
分别将0.50克比较例1与实施例1的手性分子配置于6.81克向列型液晶主体BL-087(Merck)中(双折射率为0.24)中,以UV灯(365nm;~2mW/cm2)照光0~60秒,量测其波峰半高宽(Δλ),结果如表1与图1所示。0.50 grams of the chiral molecules of Comparative Example 1 and Example 1 were arranged in 6.81 grams of nematic liquid crystal host BL-087 (Merck) (birefringence 0.24), and UV lamp (365nm; ~2mW/cm 2 ) After irradiating light for 0-60 seconds, measure its peak half-maximum width (Δλ), and the results are shown in Table 1 and Figure 1.
表1Table 1
由表1与图1可清楚看出,实施例1的手性分子所配制出的光反应型胆甾型液晶的Δλ较小,呈现出较佳的色纯度。这是由于实施例1的分子只有一个光应答基,trans至cis的光异构化反应单纯;比较例一的分子因有两个光应答基则需经过(trans,trans)至(cis,trans)或(trans,cis)过渡态,最后才至(cis,cis),导致Δλ较大。It can be clearly seen from Table 1 and FIG. 1 that the photoresponsive cholesteric liquid crystal prepared by the chiral molecule in Example 1 has a smaller Δλ and better color purity. This is because the molecule of Example 1 has only one photoresponsive group, and the photoisomerization reaction from trans to cis is simple; the molecule of Comparative Example 1 needs to go through (trans, trans) to (cis, trans) because of two photoresponsive groups. ) or (trans, cis) transition state, and finally to (cis, cis), resulting in a larger Δλ.
【温度依存性分析】【Temperature dependence analysis】
分别将0.40克比较例2与实施例1的手性分子配置于4.63克向列型液晶主体BL-087(Merck)中。将所得的胆甾型液晶配方于0℃~50℃下测量其反射波长,得到如图2与图3所示的关系图,并行线性回归,得到斜率(dλ/dT)分别为-1.05(比较例2)、-0.51(实施例1)。由此可知,本发明所得的胆甾型液晶配方对于温度较不敏感,可具有较稳定的显示品质。0.40 g of the chiral molecules of Comparative Example 2 and Example 1 were respectively configured in 4.63 g of nematic liquid crystal host BL-087 (Merck). Measure the reflection wavelength of the obtained cholesteric liquid crystal formulation at 0°C to 50°C to obtain the relationship diagrams shown in Figure 2 and Figure 3, and parallel linear regression to obtain slopes (dλ/dT) of -1.05 (compared to Example 2), -0.51 (Example 1). It can be seen that the cholesteric liquid crystal formulation obtained in the present invention is less sensitive to temperature and can have a more stable display quality.
虽然本发明已以数个较佳实施例揭露如上,然其并非用以限定本发明,任何所属技术领域中具有通常知识者,在不脱离本发明的精神和范围内,当可作任意的更动与润饰,因此本发明的保护范围当视后附的权利要求书所界定的范围为准。Although the present invention has been disclosed above with several preferred embodiments, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field may make arbitrary changes without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be defined by the appended claims.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102534318A CN102093377B (en) | 2009-12-10 | 2009-12-10 | Chiral compound and liquid crystal composition containing the compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102534318A CN102093377B (en) | 2009-12-10 | 2009-12-10 | Chiral compound and liquid crystal composition containing the compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102093377A true CN102093377A (en) | 2011-06-15 |
CN102093377B CN102093377B (en) | 2012-11-28 |
Family
ID=44126663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102534318A Active CN102093377B (en) | 2009-12-10 | 2009-12-10 | Chiral compound and liquid crystal composition containing the compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102093377B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018010540A1 (en) * | 2016-07-14 | 2018-01-18 | 京东方科技集团股份有限公司 | Chiral compound, liquid crystal material, method for fabrication thereof, and display device |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005505577A (en) * | 2001-09-24 | 2005-02-24 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Isosorbide derivatives |
-
2009
- 2009-12-10 CN CN2009102534318A patent/CN102093377B/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018010540A1 (en) * | 2016-07-14 | 2018-01-18 | 京东方科技集团股份有限公司 | Chiral compound, liquid crystal material, method for fabrication thereof, and display device |
US10619100B2 (en) | 2016-07-14 | 2020-04-14 | Boe Technology Group Co., Ltd. | Chiral compound, liquid crystal material, preparation method thereof, and display device |
Also Published As
Publication number | Publication date |
---|---|
CN102093377B (en) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI410424B (en) | Chiral compound and liquid crystal composition containing the same | |
KR102106236B1 (en) | Optical film | |
TWI410477B (en) | Liquid crystal composition and liquid crystal display employing the same | |
JP5453798B2 (en) | Compound, optical film and method for producing optical film | |
JP2011525482A (en) | Polymerizable chiral compounds containing 2,6-naphthyl units and isomannitol units and their use as chiral dopants | |
JP2010070482A (en) | Polymerizable optically active imide compound and polymerizable composition containing the same | |
WO2020175569A1 (en) | Optical anisotropic film, layered body, circularly polarizing plate, and display device | |
WO2022030381A1 (en) | Compound, composition for anisotropic dye film including said compound, anisotropic dye film, and optical element | |
CN103788961B (en) | Negative dielectric anisotropy liquid crystal compound, liquid crystal display, and electro-optical device | |
CN102093377A (en) | Chiral compound and liquid crystal composition containing the same | |
KR20150138028A (en) | Liquid crystal compound, and liquid crystal composition and liquid crystal device including the same | |
KR102142128B1 (en) | Surface energy controlled photoresponsive chiral dopants for cholesteric liquid crystal composition | |
CN103443087A (en) | Polymerizable compound, polymerizable liquid crystal composition, polymeric compound, and film | |
US20210388269A1 (en) | Compound, liquid crystal composition, cured product, optically anisotropic body, and reflective film | |
JP4515059B2 (en) | Dichroic azo dye for liquid crystal and production method thereof | |
TWI791994B (en) | Polymerizable compound, liquid crystal composition, liquid crystal display element and liquid crystal display | |
CN119264146A (en) | A chiral agent compound and a cholesteric liquid crystal composition containing the same and application thereof | |
CN118026885A (en) | Chiral photosensitive compound, intermediate and corresponding polymerizable liquid crystal composition | |
WO2013077300A1 (en) | Liquid crystal composition and chiral agent to be used therein | |
JP2025034638A (en) | Compound, liquid crystal composition and liquid crystal device | |
TWI290166B (en) | Liquid crystal compounds, liquid crystal compositions and liquid crystal device employing the same | |
CN116715585A (en) | Polymerizable chiral compound, composition, cured product, and optically anisotropic body | |
WO2024024700A1 (en) | Liquid crystal composition, optical anisotropic film, near infrared ray-absorbing dye | |
JP2024136656A (en) | Dichroic dye and liquid crystal composition thereof | |
WO2024096003A1 (en) | Aromatic amine compound, liquid crystal composition, liquid crystal element, display device, and light modulation device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |